Survival after recurrence in patients with gastric cancer who receive S-1 adjuvant chemotherapy: Exploratory analysis of the ACTS-GC trial

Overall survival in patients with re-excision of positive microscopic margins of limb and trunk wall soft tissue sarcoma operated outside of a reference center: A nationwide cohort analysis

11 p | 5 | 4

Survival outcomes of esophageal cancer patients with recurrence after curative treatments

11 p | 3 | 2

Early postoperative decrease of skeletal muscle mass predicts recurrence and poor survival after surgical resection for perihilar cholangiocarcinoma

10 p | 3 | 2

Post-recurrence survival analysis in patients with oligo-recurrence after curative esophagectomy

12 p | 9 | 2

Rationale and design of LUX-Head & Neck 1: A randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy

9 p | 11 | 2

Association between preoperative serum albumin and prognosis in patients with adrenocortical carcinoma after primary resection: A retrospective study

9 p | 11 | 1

Efficacy of adjuvant TACE on the prognosis of patients with HCC after hepatectomy: A multicenter propensity score matching from China

9 p | 1 | 1

A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer

7 p | 9 | 1

Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy

8 p | 4 | 1